Sanofi-Synthelabo (India) Ltd. - (Amalgamated) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Sanofi-Synthelabo (India) Ltd.

Based on:

M-Cap below 100cr DeciZen not available

Sanofi-Synthelabo (India) Ltd. - (Amalgamated) stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
0 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Sanofi-Synthelabo (India) Ltd.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
ROCE % 47.1%48.5%46%43.5%2.8%-12.8%2.8%46.4%19.5%15.6%-
Value Creation
Index
2.42.52.32.1-0.8-1.9-0.82.30.40.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 186216243327355409428536547607607
Sales YoY Gr.-16.1%12.5%34.3%8.8%15%4.6%25.3%2.2%10.9%-
Adj EPS 1013.317.522.61.6-3.61.16.215130
YoY Gr.-34.1%31.5%29%-92.8%-322.1%NA484%142.7%-13.6%-
BVPS (₹) 34.848.36688.890.492.894.2126142.2154.70
Adj Net
Profit
27.937.449.163.44.6-123.520.549.8430
Cash Flow from Ops. 26.144.151.753.120.768.464.51524264.7-
Debt/CF from Ops. 0000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 14%11.3%12.4%10.9%
Adj EPS 3%51.4%130.5%-13.6%
BVPS18%11.3%18%8.8%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
Return on
Equity %
33.332.130.729.21.8-4.31.15.611.18.60
Op. Profit
Mgn %
26.127.529.226.310.116.51.38.214.511.3NAN
Net Profit
Mgn %
1517.320.219.41.3-2.90.83.89.17.10
Debt to
Equity
0000000000-
Working Cap
Days
838114211998104100861702450
Cash Conv.
Cycle
18-6-7-161930-5-725170

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Sanofi-Synthelabo (India) Ltd. - (Amalgamated)

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 607 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 480 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 40.9

Management X-Ray of Sanofi-Synthelabo (India) Ltd.:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Sanofi-Synthelabo (India) Ltd. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Sanofi-Synthelabo (India) Ltd.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Sales186.16216.18243.11326.57355.44408.87427.57535.67547.25606.64
Operating Expenses 138.43156.82172.10240.65319.42375.16421.99491.53468.05539.40
Manufacturing Costs61.786.426.1411.7512.6930.5036.9339.4396.3290.12
Material Costs50.0856.6262.7570.70108.15118.3687.6493.06162.75205.09
Employee Cost 7.118.7914.3029.6543.7847.5647.1556.0964.3570.61
Other Costs 19.4684.9988.91128.55154.80178.74250.27302.95144.63173.58
Operating Profit 47.7459.3671.0185.9236.0233.715.5844.1479.2067.24
Operating Profit Margin (%) 25.6%27.5%29.2%26.3%10.1%8.2%1.3%8.2%14.5%11.1%
Other Income 0.833.549.1414.834.725.1410.0711.6221.1021.57
Interest 0.1700.0300.0100000.46
Depreciation 6.286.476.516.5033.7974.776.988.9319.0411.03
Exceptional Items 0000000122.975.770
Profit Before Tax 42.1156.4373.6194.256.94-35.928.67169.8087.0377.32
Tax 14.5318.8623.8530.452.36-0.213.9563.2231.7435.19
Profit After Tax 27.5737.5749.7663.804.58-35.714.72106.5855.2942.13
PAT Margin (%) 14.8%17.4%20.5%19.5%1.3%-8.7%1.1%19.9%10.1%6.9%
Adjusted EPS (₹)9.913.417.822.81.6-10.81.432.216.712.7
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19

Equity and Liabilities

Shareholders Fund 97.52135.09184.85248.65253.23307.52312.24417.67471.20512.76
Share Capital 282828282833.1433.1433.1433.1433.14
Reserves 69.52107.09156.85220.65225.23274.38279.10384.53438.06479.62
Minority Interest0000000000
Debt0000000000
Long Term Debt0000000000
Short Term Debt0000000000
Trade Payables19.3218.1419.6937.0939.3944.9249.9448.0672.2396.84
Others Liabilities 5.189.4512.9816.0228.6519.8412.3945.32256.07295.42
Total Liabilities 122.02162.68217.52301.76321.27372.28374.57511.05799.50905.02

Fixed Assets

Gross Block110.57111.01113.78115.76283.45285.01288.6191.87106.90112.81
Accumulated Depreciation54.4360.4766.8973.15106.68181.03255.158.9327.9738.61
Net Fixed Assets 56.1350.5446.8942.61176.77103.9833.4682.9478.9374.20
CWIP 0.060.04000.390.820.508.561.271.90
Investments 0000056.2156.2126.5726.570
Inventories28.3426.5025.9632.8256.0848.8351.8369.6958.8671.53
Trade Receivables11.7414.1217.1226.2644.5646.9247.9841.2482.0473.95
Cash Equivalents flag 18.1561.8828.41184.7224.5094.75162.77259.18314.21392.17
Others Assets 7.599.6099.1415.3518.9720.7721.8222.87237.62291.27
Total Assets 122.02162.68217.52301.76321.27372.28374.57511.05799.50905.02

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Cash Flow From Operating Activity 26.0944.1051.7453.0520.7168.4164.50151.5642.0364.70
PBT 42.1156.4373.6194.256.94-35.9291.56184.3687.0377.32
Adjustment 6.033.77-1.38-6.5330.40104.94-16.21-15.3626.7428.05
Changes in Working Capital -7.381.083.02-2.61-7.2811.636.5-8.46-34.192.51
Tax Paid -14.67-17.18-23.54-32.06-9.35-12.24-17.35-38.62-37.55-43.18
Cash Flow From Investing Activity -0.96-0.37-85.18103.26-180.92-88.163.52-55.1512.5213.26
Capex -1.16-0.85-2.82-2.28-11.21-2.23-4.21-66.44-7.94-8.08
Net Investments 00000-900000
Others 0.200.48-82.36105.54-169.714.077.7311.2920.4621.34
Cash Flow From Financing Activity -12.170-0.030-0.01900000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -12000000000
Interest Paid -0.170-0.030-0.0100000
Dividend Paid 0000000000
Others 00000900000
Net Cash Flow 12.9543.73-33.47156.31-160.2270.2568.0296.4154.5577.96

Finance Ratio

PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Ratios
ROE (%)32.9332.331.1129.431.83-12.741.5229.212.448.56
ROCE (%)47.1248.5246.0343.482.77-12.812.846.4419.4515.61
Asset Turnover Ratio1.671.541.31.281.161.21.171.230.840.71
PAT to CFO Conversion(x)0.951.171.040.834.52N/A13.671.420.761.54
Working Capital Days
Receivable Days24222324364040304147
Inventory Days46463932454642414339
Payable Days145121110147129130198192135150

Sanofi-Synthelabo (India) Ltd. - (Amalgamated) Stock News

Sanofi-Synthelabo (India) Ltd. - (Amalgamated) FAQs

The current trading price of Sanofi-Synthelabo (India) Ltd. on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Sanofi-Synthelabo (India) Ltd. stood at ₹0.00.
The latest P/E ratio of Sanofi-Synthelabo (India) Ltd. as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Sanofi-Synthelabo (India) Ltd. as of 31-Dec-1969 is 0.00.
The 52-week high of Sanofi-Synthelabo (India) Ltd. is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sanofi-Synthelabo (India) Ltd. is ₹606.6 ( Cr.) .

About Sanofi-Synthelabo (India) Ltd. - (Amalgamated)

No data to display
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×